300142.SZ · 沃森生物
China A-shares · RS rating 90 · As of 2026-10-14
| Price | 13.35 CNY |
|---|---|
| 1-day change | -5.2% |
| RS rating (overall / 1M / 3M / 12M) | 90 / 84 / 67 / 80 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 33 / 42 / 32 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -12.1% |
| Distance from 52-week high | +17.1% |
| Market cap (USD) | $3.5B |